FLAURA-2 Results Lead to Approval of Osimertinib Plus Chemotherapy in European Union, Japan

Foritinib Gains Momentum in China for ALK-positive NSCLC

IASLC Establishes Global Molecular Database for Thoracic Malignancies: A Call for Data

IASLC Journals Share Exciting Milestones on Metrics Journeys

Renowned Medical Oncologist, Investigator to Take Reins at IASLC in March

Introducing the New ILCN

IASLC’s Global Reach a Strength on the Road to a Cure for Lung Cancer

IASLC Releases Position Statement on Air Pollution on Earth Day

IASLC Responds to Call for Evidence

Renowned Researcher Fred Hirsch Delivers 2022 Heine H. Hansen Award Lecture

In Brief for June 8, 2022

In Brief for Oct. 26, 2022